Successful treatment of bronchiolitis obliterans in a bone marrow transplant patient with tumor necrosis factor-α blockade

Pediatrics

Volumn 116, Issue 3, 2005, Pages 767-770

  Fullmer, Jason J ^a   Fan, Leland L ^a,b   Dishop, Megan K ^a   Rodgers, Cheryl ^a   Krance, Robert ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b TEXAS CHILDREN S HOSPITAL   (United States)

Author keywords

Bone marrow transplant; Bronchiolitis obliterans; Tumor necrosis factor alpha

Indexed keywords

CORTICOSTEROID; INFLIXIMAB; PREDNISONE; RIBAVIRIN; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BINDING AFFINITY; BONE MARROW TRANSPLANTATION; BRONCHIOLITIS OBLITERANS; CASE REPORT; DISEASE COURSE; DRUG TOLERABILITY; FEMALE; FORCED EXPIRATORY VOLUME; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LOWER RESPIRATORY TRACT INFECTION; LUNG FUNCTION TEST; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SCHOOL CHILD; SYMPTOM; TREATMENT RESPONSE; APLASTIC ANEMIA; CHILD; DRUG ANTAGONISM;

ANEMIA, APLASTIC; ANTIBODIES, MONOCLONAL; BONE MARROW TRANSPLANTATION; BRONCHIOLITIS OBLITERANS; CHILD; FEMALE; HUMANS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33644633170     PISSN: 00314005     EISSN: 00314005     Source Type: Journal    
DOI: 10.1542/peds.2005-0806     Document Type: Article

References (18)

1. Ryu JH, Myers JL, Swensen SJ. Bronchiolar disorders. Am J Respir Crit Care Med. 2003;168:1277-1292
2. Chan PWK, Muridan R, Debruyne JA. Bronchiolitis obliterans in children: clinical profile and diagnosis. Respirology. 2000;5:369-375
3. Kotloff RM, Ahya VN, Crawford SW. Pulmonary complications of solid organ and hematopoietic stem cell transplantation. Am J Respir Crit Care Med. 2004;170:22-48
4. Yalcin E, Dogru D, Haliloglu M, Ozcelik U, Kiper N, Gocmen A. Postinfectious bronchiolitis obliterans in children: clinical and radiological profile and prognostic factors. Respiration. 2003;70:371-375
5. Hardy KA, Schidlow DV, Zacri N. Obliterative bronchiolitis in children. Chest. 1988;93:460-466
6. Kim CK, Kim SW, Koh YY, Cohen AH, Deterding RR, White CW. Bronchiolitis obliterans in the 1990s in Korea and the United States. Chest. 2001;120:1101-1106
7. Aris RM, Walsh S, Chalermskulrat W, Hathwar V, Neuringer IP. Growth factor upregulation during obliterative bronchiolitis in the mouse model. Am J Respir Crit Care Med. 2002;166:417-422
8. Mistchenko AS, Diez RA, Mariani AL, et al. Cytokines in adenoviral disease in children: association of interleukin-6, interleukin-8, and tumor necrosis factor alpha levels with clinical outcome. J Pediatr. 1994;124:714-720
9. Cooke KR, Hill GR, Gerbitz A, et al. Tumor necrosis factor-alpha neutralization reduces lung injury after experimental allogeneic bone marrow transplantation. Transplantation. 2000;70:272-279
10. Chien JW, Martin PJ, Gooley TA, et al. Airflow obstruction after myeloablative allogenic hematopoietic stem cell transplantation. Am J Respir Crit Care Med. 2003;168:208-214
11. Curtis DJ, Smale A, Thien F, Schwarer AP, Szer J. Chronic airflow obstruction in long term survivors of allogeneic bone marrow transplantation. Bone Marrow Transplant. 1995;16:169-173
12. Hertz MI, Henke CA, Nakhleh RE, et al. Obliterative bronchiolitis after lung transplantation: a fibroproliferative disorder associated with platelet-derived growth factor. Proc Natl Acad Sci USA. 1992;89:10385-10389
13. Magnan A, Mege JL, Escallier JC, et al. Balance between alveolar macrophage Il-6 and TGF-β in lung transplant recipients: Marseille and Montreal Lung Transplantation Group. Am J Respir Crit Care Med. 1996;153:1431-1436
14. Laohaburanakit P, Chan A, Allen RP. Bronchiolitis obliterans. Clin Rev Allergy Immunol. 2003;25:259-274
15. Alho HS, Maasilta PK, Harjula AL, Hammainen P, Salminen J, Salminen US. Tumor necrosis factor-alpha in a porcine bronchial model of obliterative bronchiolitis. Transplantation. 2003;76:516-523
16. Winterfield LS, Menter A. Infliximab. Dermatol Ther. 2004;17:409-426
17. Couriel D, Saliba R, Hicks K, et al. Tumor necrosis factor alpha blockade for the treatment of acute GVHD. Blood. 2004;104:649-654
18. Keane J, Gershon S, Wise RP, et al. Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N Engl J Med. 2001;345:1098-1104